ATE214373T1 - Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate - Google Patents

Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate

Info

Publication number
ATE214373T1
ATE214373T1 AT98913997T AT98913997T ATE214373T1 AT E214373 T1 ATE214373 T1 AT E214373T1 AT 98913997 T AT98913997 T AT 98913997T AT 98913997 T AT98913997 T AT 98913997T AT E214373 T1 ATE214373 T1 AT E214373T1
Authority
AT
Austria
Prior art keywords
intermediate products
indazole derivatives
producing substituted
substituted indazole
producing
Prior art date
Application number
AT98913997T
Other languages
English (en)
Inventor
Stephane Caron
Shane Allen Eisenbeis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE214373T1 publication Critical patent/ATE214373T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT98913997T 1997-05-08 1998-04-28 Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate ATE214373T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4685897P 1997-05-08 1997-05-08
PCT/IB1998/000647 WO1998050367A1 (en) 1997-05-08 1998-04-28 Processes and intermediates for preparing substituted indazole derivatives

Publications (1)

Publication Number Publication Date
ATE214373T1 true ATE214373T1 (de) 2002-03-15

Family

ID=21945777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98913997T ATE214373T1 (de) 1997-05-08 1998-04-28 Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate

Country Status (12)

Country Link
US (1) US6011159A (de)
EP (1) EP0983249B1 (de)
JP (1) JP3399546B2 (de)
AR (2) AR015648A1 (de)
AT (1) ATE214373T1 (de)
AU (1) AU6849798A (de)
DE (1) DE69804212T2 (de)
DK (1) DK0983249T3 (de)
ES (1) ES2172882T3 (de)
PT (1) PT983249E (de)
WO (1) WO1998050367A1 (de)
ZA (1) ZA983842B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
HUP0100330A3 (en) * 1997-11-04 2002-03-28 Pfizer Prod Inc Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors, compositions containing them and their use
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
KR100423899B1 (ko) * 2000-05-10 2004-03-24 주식회사 엘지생명과학 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru) * 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
EP2357174A1 (de) 2006-05-09 2011-08-17 AstraZeneca AB Salzformen von (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-Penten-2-Amin
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511758A (ja) * 1994-10-20 1997-11-25 フアイザー・インコーポレイテツド 二環式テトラヒドロピラゾロピリジンおよび医薬としてのその使用
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.

Also Published As

Publication number Publication date
EP0983249A1 (de) 2000-03-08
AU6849798A (en) 1998-11-27
US6011159A (en) 2000-01-04
EP0983249B1 (de) 2002-03-13
PT983249E (pt) 2002-08-30
JP3399546B2 (ja) 2003-04-21
ZA983842B (en) 1999-11-08
DK0983249T3 (da) 2002-07-08
WO1998050367A1 (en) 1998-11-12
AR016737A1 (es) 2001-07-25
ES2172882T3 (es) 2002-10-01
DE69804212D1 (de) 2002-04-18
DE69804212T2 (de) 2002-07-25
JP2000513019A (ja) 2000-10-03
AR015648A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69527054T2 (de) Retroreflektierender gegenstand und verfahren zur herstellung
DE69829181D1 (de) Verbesserte trennsäulen und verfahren zur herstellung der verbesserten trennsäulen
ATE258180T1 (de) Verfahren zur herstellung von glufosinate und zwischenprodukte dafür
ATE348098T1 (de) Verfahren und zwischenprodukte zur herstellung von antikrebsmitteln
DE69814862D1 (de) Verfahren zur herstellung von pyridinderivaten
DE50010110D1 (de) Verfahren zur herstellung von plattenförmigen produkten
ATE209208T1 (de) Zwischenprodukte und verfahren zur herstellung olanzapin
DE69813312D1 (de) Verfahren zur herstellung von cyclopropylethyn sowie zwischenprodukte zur herstellung von cyclopropylethyn
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
ATE195937T1 (de) Pyridazinone-derivate und verfahren zur deren herstellung
ATE249452T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE69628203D1 (de) Verfahren zur herstellung von phenylimidazolin-derivaten
DE69807660T2 (de) Verfahren zur herstellung von pyrazolderivaten
ATE238302T1 (de) Verfahren zur herstellung von thiazolidindion- derivaten
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
ATE214373T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate
ATE219056T1 (de) Verfahren zur herstellung von alpha- bromolactamderivaten
DE69808068T2 (de) Verfahren zur herstellung von indolderivaten
ATE284390T1 (de) Verfahren und zwischenprodukte zur herstellung von 2,3-pyridindicarboxylatderivaten
ATE203506T1 (de) Verfahren und zwischenprodukte zur herstellung von pestiziden-fluorolefinverbindungen
DE69611380D1 (de) Verfahren zur herstellung von dioxoazabiclohexanderivaten
DE69617643D1 (de) Verfahren zur herstellung von difluormethan und difluorchlormethan
DE59700696D1 (de) Verfahren und zwischenprodukte zur herstellung von pyridyl-4-fluoranilinen
ATE234292T1 (de) Verfahren und zwischenprodukte zur herstellung von triazolin herbiziden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee